• Phare
  • Validé par KD/KO

Anticorps Polyclonal de lapin anti-Ki-67

Ki-67 Polyclonal Antibody for IHC, IF/ICC, IF-P, FC (Intra), ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain et plus (5)

Applications

IHC, IF/ICC, IF-P, FC (Intra), ELISA

Conjugaison

Non conjugué

Publications(1327)

N° de cat : 27309-1-AP

Synonymes

KI67, MKI67, Antigen identified by monoclonal antibody Ki-67, Antigen KI-67, Ki 67



Applications testées

Résultats positifs en IHCtissu d'amygdalite humain, cellules K-562, tissu de cancer de la peau humain, tissu de cancer du côlon humain, tissu de cancer du poumon humain, tissu de cancer du sein humain, tissu de gliome humain, tissu de lymphome humain, tissu d'insulinome
il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0.
Résultats positifs en IF-Ptissu de cancer du poumon humain,
Résultats positifs en IF/ICCcellules HeLa, cellules HEK-293
Résultats positifs en FC (Intra)cellules Jurkat

Dilution recommandée

ApplicationDilution
Immunohistochimie (IHC)IHC : 1:4000-1:16000
Immunofluorescence (IF)-PIF-P : 1:50-1:500
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
Flow Cytometry (FC) (INTRA)FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

27309-1-AP cible Ki-67 dans les applications de IHC, IF/ICC, IF-P, FC (Intra), ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Réactivité citéecanin, Chèvre, Humain, poisson-zèbre, porc, Hamster
Hôte / Isotype Lapin / IgG
Clonalité Polyclonal
Type Anticorps
Immunogène Ki-67 Protéine recombinante Ag26266
Nom complet antigen identified by monoclonal antibody Ki-67
Masse moléculaire calculée 359 kDa
Numéro d’acquisition GenBankNM_002417
Symbole du gène KI67
Identification du gène (NCBI) 4288
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par affinité contre l'antigène
Tampon de stockage PBS with 0.02% sodium azide and 50% glycerol
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

The Ki-67 protein (also known as MKI67) is a cellular marker for proliferation. Ki67 is present during all active phases of the cell cycle (G1, S, G2 and M), but is absent in resting cells (G0). Cellular content of Ki-67 protein markedly increases during cell progression through S phase of the cell cycle. Therefore, the nuclear expression of Ki67 can be evaluated to assess tumor proliferation by immunohistochemistry. It has been demonstrated to be of prognostic value in breast cancer. In head and neck cancer, several studies have reported an association between high proliferative activity and poorer prognosis.

Protocole

Product Specific Protocols
IHC protocol for Ki-67 antibody 27309-1-APDownload protocol
IF protocol for Ki-67 antibody 27309-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
IHC

Signal Transduct Target Ther

FBXW7β loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth

Authors - Wenxia Wei
IHC

Mol Cancer

Cell surface CD55 traffics to the nucleus leading to cisplatin resistance and stemness by inducing PRC2 and H3K27 trimethylation on chromatin in ovarian cancer

Authors - Rashmi Bharti
IHC

Mol Cancer

lncRNA ZNRD1-AS1 promotes malignant lung cell proliferation, migration, and angiogenesis via the miR-942/TNS1 axis and is positively regulated by the m6A reader YTHDC2

Authors - Jin Wang
humanIHC

Cancer Discov

Stress Granules determine the Development of Obesity-associated Pancreatic Cancer.

Authors - Guillaume Fonteneau
IF

Adv Mater

Supramolecular Hydrogel with Ultra-Rapid Cell-Mediated Network Adaptation for Enhancing Cellular Metabolic Energetics and Tissue Regeneration

Authors - Zhuo Li
IHC

Protein Cell

NDFIP1 limits cellular TAZ accumulation via exosomal sorting to inhibit NSCLC proliferation

Authors - Yirui Cheng

Avis

The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.


FH

Udesh (Verified Customer) (08-12-2025)

Worked well in Western, also detected a non specific band at 70 kDa

  • Applications: Western Blot
  • Primary Antibody Dilution: 1:5000
  • Cell Tissue Type: MSCs
FH

Celine (Verified Customer) (07-09-2025)

Works well in immunoflurescence with fixed cells

  • Applications: Immunofluorescence
  • Primary Antibody Dilution: 1:500 O/N
  • Cell Tissue Type: glioblastoma cell lines
Ki-67 Antibody Immunofluorescence validation (1:500 O/N dilution) in glioblastoma cell lines (Cat no:27309-1-AP)
FH

Guo-rong (Verified Customer) (08-30-2022)

Clear staining

  • Applications: Immunofluorescence
  • Primary Antibody Dilution: 1:200
  • Cell Tissue Type: ARPE-19
Ki-67 Antibody Immunofluorescence validation (1:200 dilution) in ARPE-19 (Cat no:27309-1-AP)
FH

Alessandro (Verified Customer) (07-27-2022)

No aspecific staining, great outcome

  • Applications: Immunofluorescence
  • Primary Antibody Dilution: 1:250
  • Cell Tissue Type: ARPE-19
FH

Ana (Verified Customer) (02-15-2022)

Both, 1:50 and 1:100 dilutions worked well

  • Applications: Immunofluorescence
  • Primary Antibody Dilution: 1:50, 1:100
  • Cell Tissue Type: ARPE-19
FH

kes (Verified Customer) (01-17-2022)

Works at 1:200 dilution for IHC

  • Applications: Immunohistochemistry
  • Primary Antibody Dilution: 1:200
  • Cell Tissue Type: murine tissues
FH

Yan (Verified Customer) (02-18-2020)

1:100 work for cell.

  • Applications: Immunofluorescence,
{{ptg:RelatedPrimaryAntibodies}}